Simcere Pharmaceutical Enters into a Research Collaboration Agreement with Stanford Medicine to Develop Innovative Therapies for Patients with Idiopathic Pulmonary Fibrosis
SHANGHAI, June 12, 2026 /PRNewswire/ -- On May 29, 2026, Pacific Time, Simcere Pharmaceutical Group Limited (2096.HK) entered into a research collaboration agreement with Stanford Medicine to jointly advance an exploratory study in the respiratory...
MDP Enters OLIVE YOUNG
MDP launched four key SKUs at OLIVE YOUNG Pasadena, which opened on May 29. Additional rollout planned for the upcoming OLIVE YOUNG Century City location in mid-June. SEOUL, South Korea, June 9, 2026 /PRNewswire/ -- MDP, MEDIPEEL's U.S. market...
Everest Medicines Enters into Exclusive Asia-Pacific Licensing Agreement with Vcare PharmaTech for Sumecigrel
SHANGHAI, June 9, 2026 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing, and commercialization of innovative therapeutics, today...
Everest Medicines Enters into Asset Purchase Agreement with Corxel Pharmaceuticals to Develop and Commercialize LNZ100 in Greater China
SHANGHAI, June 8, 2026 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing, and commercialization of innovative therapeutics, today...
Fiddler's Green Amphitheatre Enters New Era of Connectivity with Boldyn Networks' 5G Infrastructure
AEG Presents venue in Denver now live with next-generation wireless network for seamless fan connectivity DENVER, June 4, 2026 /PRNewswire/ -- Boldyn Networks (Boldyn), a global leader in shared network infrastructure, today announced the successful...
Everest Medicines Enters Commercialization License Agreement with Mabworks for Bejescin® in the Asia-Pacific Market
Everest Medicines has obtained exclusive rights for the clinical development and commercialization of Bejescin® (MIL62, Obinutuzumab beta Injection) across the Asia-Pacific region, including Southeast Asia, India, South Korea, Australia, New...
Everest Medicines Enters into Exclusive Licensing Agreement with Travere Therapeutics for Civorebrutinib a Potential Best-in-Class BTK Inhibitor for Rare Kidney Diseases
Civorebrutinib is an investigational oral, covalent reversible BTK inhibitor designed to provide differentiated efficacy, safety and convenience in immune-mediated kidney diseases Civorebrutinib adds pipeline-in-a-product potential across multiple...
Purito Seoul Enters OLIVE YOUNG US, Accelerating North American Retail Expansion
LOS ANGELES, May 29, 2026 /PRNewswire/ -- Global K-beauty skincare brand Purito Seoul is accelerating its expansion across North America through its upcoming launch at OLIVE YOUNG US. The brand will officially meet North American consumers through...
Teamily AI Officially Enters the Singapore Market, Launching its Personal AI Agent OS -- Redefining Personal AGI Through Self-Improving AI+Human Social Network
Backed by US$20M in Seed Funding, Teamily AI Aligns with Singapore's National AI Strategy 2.0 to Redefine the Future of Human+AI Collaboration SINGAPORE, May 26, 2026 /PRNewswire/ -- Teamily AI, the Silicon Valley-based pioneer behind the world's...
Plush Toy Manufacturer Yortoob Enters Licensed Character Manufacturing Supply Chain for Global Entertainment IP
YANGZHOU, China, May 25, 2026 /PRNewswire/ -- Today, plush toy manufacturer Yangzhou Home Ka Crafts Co., Ltd. (Yortoob) announced its official entry into the licensed character manufacturing supply chain for global entertainment IPs, supported by...